3
Announcements
Trials
Browse
Landscape
Status
Completed
98
Terminated
21
Recruiting
11
Unknown
8
Withdrawn
6
Active not recruiting
6
Suspended
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
2
Thoracic
1
Head & Neck
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
47
Triple Negative Breast Neoplasms
10
Colorectal Neoplasms
6
Prostatic Neoplasms
5
Ovarian Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Uterine Cervical Neoplasms
3
Neoplasm Metastasis
3
Carcinoma, Renal Cell
3
Vulvar Neoplasms
2
Stomach Neoplasms
2
Sarcoma
2
Pancreatic Neoplasms
2
Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Transitional Cell
2
Carcinoma, Intraductal, Noninfiltrating
2
Breast Carcinoma In Situ
2
Vaginitis
1
Uterine Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Osteosarcoma
1
Neuroendocrine Tumors
1
Multiple Myeloma
1
Margins of Excision
1
Lymphedema
1
Liver Neoplasms
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Suspended
×
Carcinoma, Ovarian Epithelial
×
Breast
×
Clear all
NCT03253575
2019-04-08
ANCERS-2
Mitra RxDx, Inc.
Suspended
800 enrolled